Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_assertion type Assertion NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_head.
- NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_assertion description "[We conclude that the efficacy of intravenous t-PA in patients with acute ischemic stroke may be enhanced in patients who have an Apo E2 phenotype, whereas the Apo E2 phenotype alone is not associated with a detectable benefit on stroke outcome at 3 months in patients not given t-PA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_provenance.
- NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_assertion evidence source_evidence_literature NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_provenance.
- NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_assertion SIO_000772 11409425 NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_provenance.
- NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_assertion wasDerivedFrom befree-20140225 NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_provenance.
- NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_assertion wasGeneratedBy ECO_0000203 NP378984.RAnIse0p4UqLFERkzcpJyaunS316hEFTeQ0dS9fvL_L5o130_provenance.